The eligibility criteria for Zepbound (tirzepatide) are based on its indication for chronic weight management in adults. Patients must have a body mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with at least one weight-related comorbidity. These comorbidities can include hypertension, type 2 diabetes, or dyslipidemia [1].
Who should not take Zepbound?
Zepbound is contraindicated in patients with a history of serious hypersensitivity to tirzepatide or any of its excipients. Serious hypersensitivity reactions, including anaphylaxis, have been reported with tirzepatide [1].
What medical conditions are addressed by Zepbound?
Zepbound is approved for chronic weight management in adults who have obesity (defined as a BMI of 30 kg/m² or greater) or are overweight (BMI of 27 kg/m² or greater) and have at least one weight-related condition [1].
How does Zepbound work for weight loss?
Tirzepatide, the active ingredient in Zepbound, is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the actions of these natural hormones, which play roles in regulating appetite and blood sugar. By activating these receptors, tirzepatide helps to reduce food intake and increase feelings of fullness, contributing to weight loss [1].
Are there different dosages of Zepbound?
Zepbound is available in multiple dosage strengths: 5 mg, 10 mg, 15 mg, and 20 mg, administered subcutaneously once weekly. The starting dose is typically 2.5 mg once weekly, with gradual increases allowed based on tolerability and clinical response [1].
What are the potential side effects of Zepbound?
The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, headache, fatigue, dizziness, and potential injection site reactions. Serious side effects, though less common, can include pancreatitis, gallbladder problems, kidney problems, severe allergic reactions, and thyroid C-cell tumors [1].
What is the cost of Zepbound and is it covered by insurance?
The list price for Zepbound is approximately $1,059.87 for a 28-day supply. However, out-of-pocket costs can vary significantly depending on insurance coverage, pharmacy, and patient assistance programs. Eli Lilly, the manufacturer, offers a savings card that can reduce the cost for eligible commercially insured patients [2]. Insurance coverage for Zepbound is not universal and can depend on the specific plan and its formulary.
When did Zepbound receive FDA approval?
The U.S. Food and Drug Administration (FDA) approved Zepbound for chronic weight management on November 8, 2023 [3].
What are the alternatives to Zepbound for weight management?
Other medications approved for chronic weight management include semaglutide (Wegovy), liraglutide (Saxenda), and phentermine-topiramate (Qsymia), among others. Lifestyle interventions, including diet and exercise, are also fundamental components of weight management [4].
Sources:
[1] https://www.zepbound.com/
[2] https://www.zepbound.com/savings-and-support
[3] https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-new-drug-tirzepatide-chronic-weight-management
[4] https://www.drugpatentwatch.com/blog/new-weight-loss-drugs-approved-by-fda